Ná mmalite nke afọ a, Shanghai Pudong New Area wepụtara ihe omume atụmatụ maka elu-edu mmepe nke biopharmaceutical ụlọ ọrụ, aiming ịkwalite ọnụ ọgụgụ nke biopharmaceutical ụlọ ọrụ iru 400 ijeri yuan akara site institutional ọhụrụ. Wulite ntọala ụlọ ọrụ na-apụta atụmatụ dị n'ọkwa mba yana ụyọkọ nrụpụta dị elu ruru ijeri 100. A na-eme atụmatụ na n'afọ 2025, ọnụ ọgụgụ nke ọgwụ ọhụrụ na ụlọ ọrụ ahụike ndụ ga-agafe ijeri yuan 540; "Atụmatụ mmejuputa iwu nke mpaghara Fujian maka ịkwalite mmepe dị elu nke ụlọ ọrụ biomedical" na-atụ aro, Site na 2022 ruo 2025, a na-eme atụmatụ ịhazi ego pụrụ iche nke mpaghara nke ihe fọrọ nke nta ka ọ bụrụ 1 ijeri yuan iji kwado mmepe nke ụlọ ọrụ biomedical. Zhang Wenyang, onye so n'òtù pati ahụ na osote onye isi nke Fujian Provincial Development and Reform Commission, kwuru na ka ọ na-erule 2025, ego ụlọ ọrụ na-emepụta ọgwụ na mpaghara ahụ ga-agba mbọ iru ijeri yuan 120, na-ekepụta otu ụlọ ọrụ na-eduga n'azụ azụ, ngwaahịa ọhụrụ ọhụrụ. , nyocha teknụzụ na mmepe na nyiwe ọrụ ọha na eze na njirimara ụlọ ọrụ cluster.Ụlọ ọrụ ahụike dịkaNingbo ALPSga-esonye.
Ụlọ ọrụ na-eto eto na-adọta asọmpi isi obodo. N'afọ 2021, a ga-enwe ụlọ ọrụ 121 ọhụrụ edepụtara na ngalaba biomedical nke obodo m, mmụba nke afọ n'afọ karịa 75%; ihe fọrọ nke nta ka ọ bụrụ mmemme ego 1,900 emeela na ngalaba biomedical, na ego ego ekpughere eruola ihe karịrị ijeri yuan 260.
N'okpuru catalysis nke atumatu, teknụzụ, na isi obodo, R&D na ike ọhụrụ nke ụlọ ọrụ biopharmaceutical abawanyela nke ukwuu, ọnụ ọgụgụ ahụ abawanyela. Data sitere na National Bureau of Statistics na-egosi na na 2020, nha ahịa nke ụlọ ọrụ biopharmaceutical nke obodo m ga-eru puku ijeri yuan 3.57, mmụba kwa afọ nke 8.51%. A na-atụ anya na ọ ga-agafe puku ijeri yuan 4 na 2022.
Oge nzipu: Mee-20-2022